Chawnshang Chang

China Medical University — Taiwan

Medicine · Health Sciences

100h-index36.7kcitations678works1.72yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(249), Estrogen and related hormone effects(112), Hormonal and reproductive studies(106), Nuclear Receptors and Signaling(71), Renal cell carcinoma treatment(52)

Publications672 total

Effect of the timing of caffeine citrate discontinuation on the recurrence of apnea in very low birth weight infants
2025Open Access
A prognostic glycolysis-related gene signature in osteosarcoma: implications for metabolic programming, immune microenvironment, and drug response
PeerJ·2025· 3 citedOpen Access
Correction: Androgen receptor promotes renal cell carcinoma (RCC) vasculogenic mimicry (VM) via altering TWIST1 nonsense-mediated decay through lncRNA-TANAR
Oncogene·2025Open Access
Curcumin protects rat endplate chondrocytes against IL-1β-induced apoptosis via Bcl-2/Bax regulation
Journal of Molecular Histology·2025· 7 cited
Identification of Mitochondrial-related Characteristic Biomarkers inOsteosarcoma using Bioinformatics and Machine Learning
Combinatorial Chemistry & High Throughput Screening·2025· 1 citedOpen Access
Deciphering the oncogenic network: how C1QTNF1-AS1 modulates osteosarcoma through miR-34a-5p and glycolytic pathways
Frontiers in Oncology·2025Open Access
199 - Cold Hypersensitivity in the Hands and Feet is Associated with Erectile Dysfunction in Young Taiwanese Men
Continence·2024· 1 citedOpen Access
The androgen receptor in bladder cancer
Nature Reviews Urology·2023· 40 cited
Data from Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression
2023Open Access
Supplementary Figures 1 - 4 from Endothelial Cells Enhance Prostate Cancer Metastasis via IL-6→Androgen Receptor→TGF-β→MMP-9 Signals
2023Open Access
Supplementary figures S1-S9 from Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression
2023Open Access
Data from Endothelial Cells Enhance Prostate Cancer Metastasis via IL-6→Androgen Receptor→TGF-β→MMP-9 Signals
2023Open Access
Supplementary Table 1 from Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals
2023Open Access
Data from TR4 Nuclear Receptor Alters the Prostate Cancer CD133<sup>+</sup> Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression
2023Open Access
Supplemental figure 1 from Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression
2023Open Access
Data from Infiltrating T Cells Promote Bladder Cancer Progression via Increasing IL1→Androgen Receptor→HIF1α→VEGFa Signals
2023Open Access
Supplementary Table from Targeting Androgen Receptor (AR)→IL12A Signal Enhances Efficacy of Sorafenib plus NK Cells Immunotherapy to Better Suppress HCC Progression
2023Open Access
Data from Antiandrogen Therapy with Hydroxyflutamide or Androgen Receptor Degradation Enhancer ASC-J9 Enhances BCG Efficacy to Better Suppress Bladder Cancer Progression
2023Open Access
Supplementary Table 1 from TR4 Nuclear Receptor Alters the Prostate Cancer CD133<sup>+</sup> Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression
2023Open Access
Supplementary Figure 1 from TR4 Nuclear Receptor Alters the Prostate Cancer CD133<sup>+</sup> Stem/Progenitor Cell Invasion via Modulating the EZH2-Related Metastasis Gene Expression
2023Open Access
page 1 of 34Next →

Frequent Co-authors

Shuyuan Yeh(25), Saleh Altuwaijri(7), Hong‐Yo Kang(5), Hiroshi Miyamoto(5), Kuo‐Pao Lai(5), Qingquan Xu(4), Edward M. Messing(4), Atsushi Mizokami(4), Wen‐Lung Ma(4), Hung‐Yun Lin(4), Cynthia Heinlein(3), Meng-Yin Tsai(3), Hui‐Kuan Lin(3), Ruey-Sheng Wang(3), Chii‐Ruey Tzeng(3), Yueh‐Chiang Hu(3), Chun‐Te Wu(3), Jiann–Jyh Lai(3), Wen‐Jye Lin(3), Yin Sun(3)